Publications by authors named "M Korva"

Among the various causes of rhomboencephalitis, infection is the most common. However, conventional microbiological methods often yield negative results, making diagnosis challenging and leading to extensive, often inconclusive, diagnostics. Advanced molecular techniques like metagenomic next-generation sequencing (mNGS) offer a powerful and efficient approach to pathogen identification.

View Article and Find Full Text PDF

Over the past decade, there have been many improvements in the field of metagenomics, including sequencing technologies, advances in bioinformatics and the development of reference databases, but a one-size-fits-all sequencing and bioinformatics pipeline does not yet seem achievable. In this study, we address the bioinformatics part of the analysis by combining three methods into a three-step workflow that increases the sensitivity and specificity of clinical metagenomics and improves pathogen detection. The individual tools are combined into a user-friendly workflow suitable for analysing short paired-end (PE) and long reads from metagenomics datasets-MetaAll.

View Article and Find Full Text PDF

Tick-borne encephalitis virus (TBEV) infection may cause acute central nervous system inflammation varying in clinical manifestations and severity. A possible correlation of TBEV-specific antibody and cell-mediated immune responses, shortly after infection, with clinical manifestations, severity and long-term outcome has been poorly investigated. In a cohort of thirty early tick-borne encephalitis (TBE) patients, we assessed the magnitude, specificity and functional properties of TBEV-specific T-cell and antibody responses.

View Article and Find Full Text PDF
Article Synopsis
  • Some people who get the TBE vaccine still get sick from the virus, which is called a breakthrough infection (VBT).
  • We studied how the immune system responds in both vaccinated and unvaccinated people after they get TBE to see the differences.
  • Unvaccinated people showed strong immune responses to the virus, while vaccinated folks had weaker responses, but still had significant T cell reactions, and VBT infections led to more serious illnesses.
View Article and Find Full Text PDF
Article Synopsis
  • Paediatric patients with autoimmune rheumatic diseases (pARD) are at a higher risk for severe infections, including COVID-19, so timely vaccination with the BNT162b2 vaccine was prioritized.
  • The study compared the immune response (antibody levels) among three groups: those who had COVID-19, those who were vaccinated, and those who experienced both; data was gathered from March 2020 to April 2022.
  • Results showed that antibody responses were stronger in vaccinated individuals and those who experienced both the vaccine and infection, and the vaccine had a good safety profile, with most vaccinated pARD remaining asymptomatic for COVID-19 over a 41.3-week observation period.
View Article and Find Full Text PDF